TA
IDXX icon

TFB Advisors’s Idexx Laboratories IDXX Stock Holding History

TFB Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-640
Closed -$323K – 328
2024
Q3 		$323K Buy
640
+21
+3% +$10.2K 0.1% 233
2024
Q2 		$302K Buy
619
+75
+14% +$37.7K 0.1% 226
2024
Q1 		$255K Buy
+544
New +$297K 0.09% 228
2023
Q4 		– Sell
-485
Closed -$212K – 180
2023
Q3 		$212K Buy
485
+43
+10% +$21.4K 0.26% 98
2023
Q2 		$222K Buy
442
+31
+8% +$14.9K 0.1% 211
2023
Q1 		$206K Buy
+411
New +$197K 0.16% 131

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

TFB Advisors's IDXX Position: Q4 2024 in Review

TFB Advisors sold out of Idexx Laboratories (IDXX) in Q4 2024, closing a stake of 640 shares — an estimated $323K sold.

TFB Advisors first reported a position in IDXX in Q1 2023 and held it in 6 quarters. The position peaked at $323K in Q3 2024. 1,124 funds tracked by Wall St. Rank hold IDXX as of Q4 2024.

  • TFB Advisors reported no remaining Idexx Laboratories position as of Q4 2024 after selling out during the quarter.
  • TFB Advisors sold 640 Idexx Laboratories shares in Q4 2024, an estimated $323K.
  • TFB Advisors first reported a position in Idexx Laboratories in Q1 2023 and held it in 6 quarters.
  • TFB Advisors's Idexx Laboratories position peaked at $323K in Q3 2024.
  • 1,124 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2024.

Based on TFB Advisors's 13F filing for Q4 2024, filed 29 Jan 2025.